MedKoo Cat#: 599029 | Name: Lithospermidin B

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Lithospermidin B is a minor pigment isolated from the roots of L. erythrorhizon.

Chemical Structure

Lithospermidin B
CAS#83415-79-6

Theoretical Analysis

MedKoo Cat#: 599029

Name: Lithospermidin B

CAS#: 83415-79-6

Chemical Formula: C21H24O7

Exact Mass: 388.1522

Molecular Weight: 388.41

Elemental Analysis: C, 64.94; H, 6.23; O, 28.83

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Lithospermidin B;
IUPAC/Chemical Name
(E)-1-(5,8-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-4-hydroxy-4-methylpent-2-en-1-yl 3-methylbutanoate
InChi Key
YEXHSSJAIYSMOW-BQYQJAHWSA-N
InChi Code
InChI=1S/C21H24O7/c1-11(2)9-17(25)28-16(7-8-21(3,4)27)12-10-15(24)18-13(22)5-6-14(23)19(18)20(12)26/h5-8,10-11,16,22-23,27H,9H2,1-4H3/b8-7+
SMILES Code
CC(CC(OC(C1=CC(c2c(C1=O)c(O)ccc2O)=O)/C=C/C(C)(O)C)=O)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 388.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Fabreti-Oliveira RA, Santos MA, Oliveira CK, Vale EM, Vilela B, Nascimento E. Description of five novel HLA-B alleles, B*07:184, B*41:27, B*42:19, B*50:32 and B*57:63, identified in Brazilian individuals. Int J Immunogenet. 2014 Jun;41(3):264-6. doi: 10.1111/iji.12110. Epub 2014 Feb 5. PubMed PMID: 24495217. 2: Haas KM. B-1 lymphocytes in mice and nonhuman primates. Ann N Y Acad Sci. 2015 Dec;1362:98-109. doi: 10.1111/nyas.12760. Epub 2015 Apr 30. Review. PubMed PMID: 25930711; PubMed Central PMCID: PMC4627897. 3: Baumgarth N. B-1 Cell Heterogeneity and the Regulation of Natural and Antigen-Induced IgM Production. Front Immunol. 2016 Sep 9;7:324. doi: 10.3389/fimmu.2016.00324. eCollection 2016. Review. PubMed PMID: 27667991; PubMed Central PMCID: PMC5016532. 4: Popi AF. B-1 phagocytes: the myeloid face of B-1 cells. Ann N Y Acad Sci. 2015 Dec;1362:86-97. doi: 10.1111/nyas.12814. Epub 2015 Jul 6. Review. PubMed PMID: 26149496. 5: Yang S, Li JY, Xu W. Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma. Crit Rev Oncol Hematol. 2014 Aug;91(2):113-22. doi: 10.1016/j.critrevonc.2014.02.004. Epub 2014 Feb 23. Review. PubMed PMID: 24629840. 6: Dickinson GS, Akkoyunlu M, Bram RJ, Alugupalli KR. BAFF receptor and TACI in B-1b cell maintenance and antibacterial responses. Ann N Y Acad Sci. 2015 Dec;1362:57-67. doi: 10.1111/nyas.12772. Epub 2015 May 11. Review. PubMed PMID: 25962322. 7: Pedersen GK, Ádori M, Karlsson Hedestam GB. NF-κB signaling in B-1 cell development. Ann N Y Acad Sci. 2015 Dec;1362:39-47. doi: 10.1111/nyas.12800. Epub 2015 Jun 11. Review. PubMed PMID: 26096766. 8: Koenig V, Stanga Z, Zerlauth M, Bernasconi L, Risch M, Huber A, Risch L. Prevalence of vitamin B(12) depletion and deficiency in Liechtenstein. Public Health Nutr. 2014 Feb;17(2):241-7. doi: 10.1017/S1368980012005289. Epub 2012 Dec 14. PubMed PMID: 23237337. 9: Montecino-Rodriguez E, Li K, Fice M, Dorshkind K. Murine B-1 B cell progenitors initiate B-acute lymphoblastic leukemia with features of high-risk disease. J Immunol. 2014 Jun 1;192(11):5171-8. doi: 10.4049/jimmunol.1303170. Epub 2014 Apr 21. PubMed PMID: 24752443; PubMed Central PMCID: PMC4028370. 10: Dusek P, Kotaska K, Vesely S, Prusa R, Babjuk M. Diagnostic Efficiency of Serum and Urine Procathepsin B and Cathepsin B in Patients with Carcinoma of the Urinary Bladder. Clin Lab. 2016 Sep 1;62(9):1709-1715. doi: 10.7754/Clin.Lab.2016.160135. PubMed PMID: 28164592. 11: Sasaki Y, Iwai K. Roles of the NF-κB Pathway in B-Lymphocyte Biology. Curr Top Microbiol Immunol. 2016;393:177-209. doi: 10.1007/82_2015_479. Review. PubMed PMID: 26275874. 12: Nitschke L. Siglec-G is a B-1 cell inhibitory receptor and also controls B cell tolerance. Ann N Y Acad Sci. 2015 Dec;1362:117-21. doi: 10.1111/nyas.12826. Epub 2015 Jul 20. Review. PubMed PMID: 26194636. 13: Muzzio DO, Soldati R, Rolle L, Zygmunt M, Zenclussen AC, Jensen F. B-1a B cells regulate T cell differentiation associated with pregnancy disturbances. Front Immunol. 2014 Jan 21;5:6. doi: 10.3389/fimmu.2014.00006. eCollection 2014. PubMed PMID: 24478775; PubMed Central PMCID: PMC3896948. 14: Yenson V, Baumgarth N. Purification and immune phenotyping of B-1 cells from body cavities of mice. Methods Mol Biol. 2014;1190:17-34. doi: 10.1007/978-1-4939-1161-5_2. PubMed PMID: 25015270. 15: Ravazzi-Gauch C, Bajay MM, Caldas HC, Abbud-Filho M. HLA-A, -B, and -DRB1 allele and haplotype diversity in a cohort of Brazilian renal transplant candidates. Hum Immunol. 2016 Jun;77(6):464-9. doi: 10.1016/j.humimm.2016.04.017. Epub 2016 Apr 22. Review. PubMed PMID: 27108963. 16: Zhou Y, You MJ, Young KH, Lin P, Lu G, Medeiros LJ, Bueso-Ramos CE. Advances in the molecular pathobiology of B-lymphoblastic leukemia. Hum Pathol. 2012 Sep;43(9):1347-62. doi: 10.1016/j.humpath.2012.02.004. Epub 2012 May 8. Review. PubMed PMID: 22575265. 17: Darke C, Corbin SA. External quality assessment of patient HLA-B*57:01 testing prior to abacavir prescription. Int J Immunogenet. 2014 Aug;41(4):277-80. doi: 10.1111/iji.12122. Epub 2014 Apr 25. PubMed PMID: 24762294. 18: Street J, Davies E, Darke C. A novel HLA-B*14 allele - B*14:53 - genetics and serology. Int J Immunogenet. 2016 Aug;43(4):236-9. doi: 10.1111/iji.12278. Epub 2016 Jun 16. PubMed PMID: 27312672. 19: Zhang Y, Wang JY, Han W. A role for CMTM7 in BCR expression and survival in B-1a but not B-2 cells. Int Immunol. 2014 Jan;26(1):47-57. doi: 10.1093/intimm/dxt042. Epub 2013 Sep 30. PubMed PMID: 24080084. 20: Holodick NE, Vizconde T, Rothstein TL. Splenic B-1a Cells Expressing CD138 Spontaneously Secrete Large Amounts of Immunoglobulin in Naïve Mice. Front Immunol. 2014 Mar 28;5:129. doi: 10.3389/fimmu.2014.00129. eCollection 2014. PubMed PMID: 24734034; PubMed Central PMCID: PMC3975111.